By:
On:
In: Commentary
With: 0 Comments

Being rich is really about having it all. It would be ideal to have a combination of: the happy family enjoying a delectable meal in the big house. However, to achieve this kind of wealth, along with financial freedom, personal peace and happiness, you must get committed to it.

You must also be able to enjoy your wealth. Some people put in a hundred hours per week with work but completely neglect their families in the process. Others focus on their family so much that they never really get busy at work because of their obligations. Obviously, achieving a sense of balance will allow you to possess true wealth and also be able to enjoy it.

If you’re looking to have it all in life, here are the only five ways you can become rich:

  1. Adopt the Producer Mentality
  2. Know Your Daily Rate
  3. Sacrifice Everything
  4. Only Do Wealthy Activities
  5. Use Your Gifts

If you want to read more about these 5 methods, I suggest you jump over to my source: The Only 5 Ways You Can Become Rich by @theallywayint

By:
On:
In: Around the web
Tagged:
With: 0 Comments

Abiomed [stckqut]ABMD[/stckqut] may be set up for a great investment with its recent drop.

Days after reporting better-than-expected financial results for its fiscal third quarter of 2016, shares in Abiomed tumbled 12.5% on 2/8/16.

On Feb. 4, Abiomed management reported that sales in its fiscal third quarter grew 38% year over year to $85.8 million. The increase was driven by a 45% lift in patient use of its Impella heart-pumping devices, which can be used for up to six hours in patients undergoing certain heart surgeries.

Abiomed’s management also reported that its adjusted net income was $0.23 in the quarter, which was nicely higher than industry watcher’s $0.15 projections.

Because the results were ahead of investors’ expectations, it appears that weakness in Abiomed’s shares this week is tied to profit-taking and de-risking amid a broader market sell-off. Since ABMD shares were up a whopping 137% last year, it’s not a stretch to think that some investors happily rang the register.

The fiscal third-quarter performance was strong enough that management bumped up its full-year forecast for fiscal 2016.

The company now expects that revenue will be roughly $326 million for the fiscal year. Previously, it was guiding for sales of between $305 million and $315 million. The forecast implies year-over-year growth of 41%, and that’s nicely above prior projections for between 32% and 37% growth.

With the stock price ‘on sale’ for over 10% of a reasonable price, this may be a good time to pick up more shares for a company that is doing very well.

Source: Why Abiomed Inc. Shares Crashed 12% Today — The Motley Fool

By:
On:
In: Around the web
Tagged:
With: 0 Comments

Helmerich & Payne, Inc. [stckqut]HP[/stckqut] issued its quarterly earnings data on Thursday. The company reported $0.15 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.22, Market Beat.com reports. During the same period last year, the firm posted $1.70 earnings per share.

An institutional investor recently raised its position in Helmerich & Payne stock. Simplex Trading raised its position in Helmerich & Payne, Inc. by 302.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 14,670 shares of the company’s stock after buying an additional 11,023 shares during the period. Simplex Trading’s holdings in Helmerich & Payne were worth $785,000 at the end of the most recent quarter.

Several equities analysts have recently issued reports on the company. Scotiabank raised Helmerich & Payne from a “sector perform” rating to a “sector outperform” rating in a report on Friday, October 9th. Stephens lowered Helmerich & Payne from an “outperform” rating to an “equal weight” rating and cut their price target for the company from $79.00 to $74.00 in a research note on Tuesday, November 3rd. Zacks Investment Research lowered Helmerich & Payne from a “hold” rating to a “sell” rating in a research note on Thursday, October 15th. Guggenheim upgraded Helmerich & Payne from a “neutral” rating to a “buy” rating and set a $70.00 price target for the company in a research note on Monday, November 30th. Finally, Scotia Howard Weill upgraded Helmerich & Payne to a “sector outperform” rating in a research note on Thursday, October 8th. Four research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $60.38.

Source: Helmerich & Payne, Inc. (HP) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPS – Zolmax

By:
On:
In: Around the web
Tagged:
With: 0 Comments

 

Under Armour [stckqut]UA[/stckqut] shares soared 16.08% to $79.61 on Thursday after the athletic apparel maker reported its fourth quarter fiscal 2015 financial results that topped analysts’ expectations.

Profit came in at 48 cents a share, 2 cents higher than estimates. Revenue of $1.17 billion was also above forecasts of $1.12 billion.

The company saw a double-digit growth in earnings as profit increased 20% and revenue surged 31% year-over-year. This was largely helped by robust footwear and apparel sales increasing 95% and 22%, respectively.

Overall, demand for its sports footwear and apparel was boosted by the company’s sponsorship deals with basketball star Stephen Curry and golfer Jordan Spieth.

Under Armour projects 2016 revenue to be $4.95 billion, above analysts’ forecasts of $4.91 billion.

Source: Under Armour (UA) Stock Soars on Quarterly Earnings, Upbeat 2016 Guidance – TheStreet

By:
On:
In: Around the web
Tagged:
With: 0 Comments

Facebook [stckqut]FB[/stckqut] is doing a darn good job of living up to lofty expectations.

The social network reported fourth-quarter earnings and revenue that handily exceeded estimates. Indeed, Facebook’s sales rose 57% from a year earlier to $5.6 billion—their fastest growth rate since the third quarter of 2014. Mobile advertising was 80% of total advertising revenue, up from 69% in 2014’s fourth quarter. And Facebook’s average revenue per user was $3.73, a 33% year-over-year increase, even as its monthly active-user base climbed 14% to 1.59 billion.

That kind of growth is impressive for any company. It is even more so for one with $18 billion in annual sales and an immense user base. Yet Facebook has continued to churn out quarter after quarter of consistently strong results.

Of course, investors are still paying a fairly steep price for that consistency. Facebook trades at 52 times 2016 consensus estimates for its earnings on the basis of generally accepted accounting principles. That is considerably pricier than it looks when using the adjusted earnings metrics the company and Wall Street prefer. On that basis, it trades at only 33 times.

Source: Facebook: It’s Hard to Argue With Results Like These